Chugai Invests in Western Startups | Pharma News
- Tokyo-based Chugai Pharmaceutical is broadening its "open innovation" strategy by investing in four European and American startups through its corporate venture capital arm.
Chugai Pharmaceutical is making a significant move in the pharmaceutical industry, injecting capital into four promising Western startups. This strategic investment, executed through their corporate venture capital arm, signals a robust commitment to open innovation and expanding their research capabilities. The initiative focuses on European and American companies, hinting at a global strategy to foster collaboration and access cutting-edge technologies.News Directory 3 is watching closely as Chugai’s move could redefine industry benchmarks. Details were unveiled in a recent investor briefing, highlighting this proactive approach to pharmaceutical research. Discover what’s next as Chugai’s investments unfold.
Chugai Pharmaceutical Expands Pharmaceutical Research with Startup Investments
Updated June 13,2025
Tokyo-based Chugai Pharmaceutical is broadening its “open innovation” strategy by investing in four European and American startups through its corporate venture capital arm. The company shared details of the investments during a briefing for journalists and investors Friday.